DOMINOS PIZZA ENTERPRISES LIMITED UNSP ADR EACH REPR 0.5 ORD SHS
DMZPY
Halozyme Therapeutics
HALO
Teradata Corp
TDC
Collegium Pharmaceutical
COLL
Hutchmed (China)
HCM
(FY)Sep 30, 2024 | (FY)Sep 30, 2023 | (FY)Sep 30, 2022 | (FY)Sep 30, 2021 | (FY)Sep 30, 2020 | (FY)Sep 30, 2019 | (FY)Sep 30, 2018 | (FY)Sep 30, 2017 | (FY)Sep 30, 2016 | (FY)Sep 30, 2015 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | 12.71%25.52B | 10.30%22.64B | -23.65%20.53B | 12.72%26.89B | -7.09%23.85B | 9.30%25.67B | 12.94%23.49B | 26.78%20.8B | 12.00%16.4B | 12.27%14.65B |
Operating revenue | 12.71%25.52B | 10.30%22.64B | -23.65%20.53B | 12.72%26.89B | -7.09%23.85B | 9.30%25.67B | 12.94%23.49B | 26.78%20.8B | 12.00%16.4B | 12.27%14.65B |
Cost of revenue | 9.31%7.71B | 11.37%7.05B | -25.81%6.33B | 16.78%8.54B | -2.84%7.31B | 9.36%7.53B | 16.33%6.88B | 24.32%5.92B | 11.27%4.76B | 11.62%4.28B |
Gross profit | 14.25%17.81B | 9.83%15.59B | -22.65%14.19B | 10.93%18.35B | -8.86%16.54B | 9.27%18.15B | 11.59%16.61B | 27.79%14.88B | 12.29%11.65B | 12.54%10.37B |
Operating expense | 12.99%15.12B | 10.31%13.38B | -22.51%12.13B | 6.96%15.65B | 1.11%14.63B | 11.59%14.47B | 14.08%12.97B | 40.74%11.37B | 16.13%8.08B | 12.27%6.96B |
Selling and administrative expenses | 24.96%1.44B | 24.19%1.15B | 0.98%926M | 4.80%917M | -7.60%875M | 37.05%947M | 43.66%691M | 165.75%481M | 17.53%181M | 14.07%154M |
-Selling and marketing expense | 20.24%101M | --84M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
-General and administrative expense | 25.33%1.34B | 15.12%1.07B | 0.98%926M | 4.80%917M | -7.60%875M | 37.05%947M | 43.66%691M | 165.75%481M | 17.53%181M | 14.07%154M |
-Depreciation and amortization | 13.14%1.27B | 14.90%1.13B | -53.42%980M | 1.84%2.1B | 13.39%2.07B | 9.10%1.82B | 18.44%1.67B | 108.27%1.41B | 18.36%677M | 19.92%572M |
Other operating expenses | 18.68%2.28B | -2.04%1.92B | -38.84%1.96B | 7.36%3.21B | 5.03%2.99B | 9.59%2.85B | -0.65%2.6B | 52.27%2.61B | 29.71%1.72B | 11.18%1.32B |
Operating profit | 21.89%2.69B | 6.98%2.21B | -23.46%2.06B | 41.34%2.69B | -48.12%1.91B | 1.02%3.67B | 3.53%3.64B | -1.54%3.51B | 4.48%3.57B | 13.12%3.42B |
Net non-operating interest income expense | 64.48%-184M | -58.90%-518M | 49.14%-326M | 21.25%-641M | 13.59%-814M | 2.08%-942M | 21.08%-962M | -143.80%-1.22B | -15.47%-500M | -108.17%-433M |
Non-operating interest income | 328.57%240M | 43.59%56M | 56.00%39M | 733.33%25M | 200.00%3M | -50.00%1M | -96.67%2M | 1,400.00%60M | -42.86%4M | -68.18%7M |
Non-operating interest expense | -26.99%422M | 61.90%578M | -43.69%357M | -11.94%634M | -3.61%720M | 2.47%747M | -34.21%729M | 255.13%1.11B | 10.64%312M | 69.88%282M |
Total other finance cost | 150.00%2M | -150.00%-4M | -75.00%8M | -67.01%32M | -50.51%97M | -16.60%196M | 37.43%235M | -10.94%171M | 21.52%192M | 146.88%158M |
Other net income (expense) | ||||||||||
Special income (charges) | -33.06%-161M | -139.67%-121M | 577.78%305M | -16.67%45M | -95.33%54M | 4,385.19%1.16B | 93.69%-27M | -12.34%-428M | -2,440.00%-381M | -101.59%-15M |
-Less:Restructuring and merger&acquisition | 92.59%156M | 124.55%81M | -11,100.00%-330M | -70.00%3M | -94.76%10M | 78.50%191M | -52.23%107M | 1,766.67%224M | -20.00%12M | -6.25%15M |
-Less:Impairment of capital assets | --25M | --0 | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
-Less:Other special charges | -150.00%-20M | 60.00%40M | 140.32%25M | 10.14%-62M | 95.44%-69M | -4,220.00%-1.51B | -194.59%-35M | 3,800.00%37M | ---1M | ---- |
-Write off | ---- | ---- | ---- | 180.00%14M | -96.95%5M | 464.44%164M | -126.95%-45M | -54.86%167M | --370M | --0 |
Other non- operating income (expenses) | 8.83%308M | 10.12%283M | 24.15%257M | -4.61%207M | -12.85%217M | 49.10%249M | 91.95%167M | -55.15%87M | 90.20%194M | -21.54%102M |
Income before tax | 42.70%2.73B | -12.78%1.91B | -9.05%2.19B | 72.94%2.41B | -62.41%1.39B | 30.63%3.71B | 46.69%2.84B | -32.47%1.93B | -7.97%2.86B | -21.67%3.11B |
Income tax | 11.39%538M | -31.29%483M | 9.50%703M | 15.47%642M | -33.41%556M | -9.53%835M | 13.25%923M | -8.84%815M | 1.13%894M | 1.03%884M |
Net income | 1,029.45%4.95B | -74.45%438M | -7.55%1.71B | 4,778.95%1.85B | -98.68%38M | 50.00%2.87B | 71.05%1.91B | -43.20%1.12B | -11.58%1.97B | -28.08%2.23B |
Net income continuous Operations | 53.29%2.19B | -4.03%1.43B | -15.79%1.49B | 111.11%1.77B | -70.85%837M | 50.00%2.87B | 71.05%1.91B | -43.20%1.12B | -11.58%1.97B | -28.08%2.23B |
Net income discontinuous operations | 378.59%2.76B | -538.05%-990M | 159.77%226M | 110.89%87M | ---799M | ---- | ---- | ---- | ---- | ---- |
Minority interest income | -31.03%120M | -4.92%174M | 83.00%183M | -23.66%100M | -56.62%131M | -10.91%302M | 11.15%339M | -13.84%305M | -2.21%354M | 11.73%362M |
Net income attributable to the parent company | 1,728.41%4.83B | -82.76%264M | -12.71%1.53B | 1,986.02%1.75B | -103.62%-93M | 63.11%2.57B | 93.49%1.58B | -49.63%814M | -13.40%1.62B | -32.73%1.87B |
Preferred stock dividends | 0 | 0 | ||||||||
Other preferred stock dividends | 83M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Net income attributable to common stockholders | 1,696.97%4.74B | -82.76%264M | -12.71%1.53B | 1,986.02%1.75B | -103.62%-93M | 63.11%2.57B | 93.49%1.58B | -49.63%814M | -13.40%1.62B | -32.73%1.87B |
Basic earnings per share | 1,696.72%13.152 | -82.70%0.732 | -7.68%4.232 | 1,890.63%4.584 | -103.63%-0.256 | 62.43%7.056 | 74.60%4.344 | -56.84%2.488 | -8.25%5.764 | -29.82%6.2826 |
Diluted earnings per share | 1,706.59%13.152 | -82.72%0.728 | -7.87%4.212 | 1,885.94%4.572 | -103.64%-0.256 | 62.63%7.032 | 74.35%4.324 | -56.85%2.48 | -8.15%5.748 | -29.88%6.2581 |
Dividend per share | 12.63%1.8782 | 3.50%1.6675 | 1.6112 | 0 | -42.25%2.0758 | 3.5944 | 0 | 3.0536 | 0 | 124.13%4.7087 |
Currency Unit | ZAR | ZAR | ZAR | ZAR | ZAR | ZAR | ZAR | ZAR | ZAR | ZAR |